Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Faruque Pathan

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Diabetes Research and Clinical Practice|May 8, 2013
Safety and effectiveness of biphasic insulin aspart 30 in a Bangladeshi subgroup of type 2 diabetic patients switched from biphasic human insulin 30: a sub-analysis of the A₁chieve studyZafar Ahmed Latif, Md Faruque Pathan, Md Nazrul Islam Siddiqui, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|August 25, 2016
Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE studyAhmed Ak Hassoun, Md Faruque Pathan, Rita C Medlej, et al.
Indian Journal of Endocrinology and Metabolism|July 28, 2012
Diabetic emergencies including hypoglycemia during RamadanJamal Ahmad, Md Faruque Pathan, Mohammed Abdul Jaleel, et al.
Indian Journal of Endocrinology and Metabolism|July 28, 2012
South Asian Consensus Guideline: Use of GLP-1 analogue therapy in diabetes during RamadanMd Faruque Pathan, Rakesh Kumar Sahay, Abdul Hamid Zargar, et al.
Indian Journal of Endocrinology and Metabolism|July 28, 2012
Thyroid diseases and RamadanSyed A Raza, Osama Ishtiaq, A G Unnikrishnan, et al.
Indian Journal of Endocrinology and Metabolism|July 28, 2012
Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during RamadanMir Iftikhar Bashir, Md Faruque Pathan, Syed Abbas Raza, et al.
Indian Journal of Endocrinology and Metabolism|February 24, 2016
Biosimilar insulins: Informed choice for South AsiaSanjay Kalra, A K Azad Khan, Syed Abbas Raza, et al.
Indian Journal of Endocrinology and Metabolism|July 28, 2012
Guidelines regarding management of adrenal insufficiency in the Holy month of RamadanSheelu S Siddiqi, S K Singh, Shakeel Ahamad Khan, et al.
JPMA. the Journal of the Pakistan Medical Association|June 25, 2016
South Asian consensus guideline: Use of GLP-1 receptor agonists during Ramadan: Update 2016 Revised Guidelines on the use of GLP-1A in RamadanFaruque Pathan, Zafar Ahmed Latif, Rakesh Kumar Sahay, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 27, 2021
Bangladesh Endocrine Society (BES) Position Statement for Management of Diabetes and Other Endocrine Diseases in Patients with COVID-19Faruque Pathan, Shahjada Selim, Md Fariduddin, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Diabetes Research and Clinical Practice|May 8, 2013
Safety and effectiveness of biphasic insulin aspart 30 in a Bangladeshi subgroup of type 2 diabetic patients switched from biphasic human insulin 30: a sub-analysis of the A₁chieve studyZafar Ahmed Latif, Md Faruque Pathan, Md Nazrul Islam Siddiqui, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|August 25, 2016
Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE studyAhmed Ak Hassoun, Md Faruque Pathan, Rita C Medlej, et al.
Indian Journal of Endocrinology and Metabolism|July 28, 2012
Diabetic emergencies including hypoglycemia during RamadanJamal Ahmad, Md Faruque Pathan, Mohammed Abdul Jaleel, et al.
Indian Journal of Endocrinology and Metabolism|July 28, 2012
South Asian Consensus Guideline: Use of GLP-1 analogue therapy in diabetes during RamadanMd Faruque Pathan, Rakesh Kumar Sahay, Abdul Hamid Zargar, et al.
Indian Journal of Endocrinology and Metabolism|July 28, 2012
Thyroid diseases and RamadanSyed A Raza, Osama Ishtiaq, A G Unnikrishnan, et al.
Indian Journal of Endocrinology and Metabolism|July 28, 2012
Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during RamadanMir Iftikhar Bashir, Md Faruque Pathan, Syed Abbas Raza, et al.
Indian Journal of Endocrinology and Metabolism|February 24, 2016
Biosimilar insulins: Informed choice for South AsiaSanjay Kalra, A K Azad Khan, Syed Abbas Raza, et al.
Indian Journal of Endocrinology and Metabolism|July 28, 2012
Guidelines regarding management of adrenal insufficiency in the Holy month of RamadanSheelu S Siddiqi, S K Singh, Shakeel Ahamad Khan, et al.
JPMA. the Journal of the Pakistan Medical Association|June 25, 2016
South Asian consensus guideline: Use of GLP-1 receptor agonists during Ramadan: Update 2016 Revised Guidelines on the use of GLP-1A in RamadanFaruque Pathan, Zafar Ahmed Latif, Rakesh Kumar Sahay, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 27, 2021
Bangladesh Endocrine Society (BES) Position Statement for Management of Diabetes and Other Endocrine Diseases in Patients with COVID-19Faruque Pathan, Shahjada Selim, Md Fariduddin, et al.
Pageof 5